• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Industrials·300412.SZ
Share

Zhejiang Canaan Technology Limited Stocks

CN¥ 4.15Last Updated 14.07.2026

Issuer Rating

4/7
Performance

Average

Risk

Moderate

Recommendation

Hold

Market Cap

CN¥ 307.06M

CN¥ 4.15
Key Takeaways

Risk factor

High price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Zhejiang Canaan Technology Co., Ltd. is a Chinese enterprise specializing in the design, production, and sale of advanced pharmaceutical machinery. Its extensive product portfolio caters broadly to the pharmaceutical industry, particularly within the Oral Solid Dosage (OSD) segment. This includes essential equipment such as dispensing units, high shear mixers, roller compactors, fluid beds, mills, pelleting and coating machines, tablet presses, capsule fillers, and various associated components like pharma lifters, washing machines, and pharma bins. Beyond OSD, Canaan Technology also supplies specialized solutions including OEB equipment, isolators, machinery for research and development, API production systems, packaging solutions, water purification systems, extraction and reactor units, and warehouse logistics products. The company's core clientele operates within the pharmaceutical industry. Established in 2000, Zhejiang Canaan Technology maintains its corporate headquarters in Wenzhou, China.

Company Valuation

Overvalued
2/7

Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA, und

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

14.07.2026 20:52

BofA recommended selling Papa John's stock. What raised analysts' concerns?

14.07.2026 20:41

Trump has lifted the requirement for ships to pay a toll to pass through the Strait of Hormuz

14.07.2026 19:14

"Life is unpredictable": Buffett has set a deadline for distributing his shares

14.07.2026 18:30

Revolut Will Participate in Testing the Digital Euro

14.07.2026 18:12

Oil at $87, Houthi attacks, strikes on UAE tankers: What’s happening in the Middle East?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026